When a neuron ages, it loses synaptic connections with other neurons, it is less able to transmit nerve impulses, and its metabolism is also altered. This process of neuronal aging — inevitable with the passing of time — is particularly accelerated and becomes a risk factor in neurodegenerative pathologies such as Alzheimer’s disease.
Rocket’s gene therapy gets a PDUFA date; SAB Biotherapeutics’ $130M; Acurix to move to PhIII
Plus, more news from Amicus Therapeutics, Mogrify, and Clade Therapeutics. Rocket gets a March date with FDA: The FDA has until March 31 to decide
October 3, 2023